Patricia A Bradford (Patricia Bradford, Fupin Hu)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 21

Top Venues

Antimicrobial agents and chemotherapy

The Journal of antimicrobial chemotherapy

Journal of clinical microbiology

mSphere

Antimicrobial Development Specialists, LLC

Creighton University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Antimicrobial Development Specialists, LLC Jul 01 2016

United States

Owner, Founder

AstraZeneca R&D Boston - Jun 30 2016

United States

Executive Director, Microbiology :: Infectious Disease

Novartis Institutes for BioMedical Research Inc

United States

Director, Applied Sciences core technologies :: Infectious Disease

Wyeth

United States

Principal Scientist :: Infectious Disease Research

Methodist Hospital

United States

Medical Technologist, Microbiology :: Pathology Center

Education History

Creighton University

United States

PHD :: Medical Microbiology

University of Nebraska Medical Center

United States

BSC

Publications

Sarah M McLeod, Nicole M Carter, Michael D Huband, Maria M Traczewski, Patricia A Bradford, Alita A Miller
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests. Journal of clinical microbiology (2023)
Antoní Torres, Michele Wible, Margaret Tawadrous, Paurus Irani, Gregory G Stone, Alvaro Quintana, Dmitri Debabov, Margaret Burroughs, Patricia A Bradford, Marin Kollef
Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme. The Journal of antimicrobial chemotherapy (2023)
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: resistance in vitro. The Journal of antimicrobial chemotherapy (2023)
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: resistance in vitro. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Wright W Nichols, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: microbiology from clinical studies, and development of resistance during treatment. The Journal of antimicrobial chemotherapy (2023)
Wright W Nichols, Sushmita D Lahiri, Patricia A Bradford, Gregory G Stone
The primary pharmacology of ceftazidime/avibactam: resistance in vitro. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Karen Bush, David C Hooper, Robert A Bonomo, Patricia A Bradford, George Eliopoulos, Pentti Huovinen, Antone A Medeiros, Barbara Murray, Alain Philippon, Louis B Rice
A Tribute to George A. Jacoby. Antimicrobial agents and chemotherapy 66 (6) (2022)
Patricia A Bradford, Robert A Bonomo, Karen Bush, Alessandra Carattoli, Michael Feldgarden, Daniel H Haft, Yoshikazu Ishii, George A Jacoby, William Klimke, Timothy G Palzkill, Laurent Poirel, Gian Maria Rossolini, Pranita D Tamma, César A Arias
Consensus on β-Lactamase Nomenclature. Antimicrobial agents and chemotherapy 66 (4) (2022)
Mariana Castanheira, Patricia J Simner, Patricia A Bradford
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection. JAC-antimicrobial resistance 3 (3) (2021)
Dong Dong, Yonggui Zheng, Qingqing Chen, Yan Guo, Yang Yang, Shi Wu, Demei Zhu, Daniel Deng, Patricia A Bradford, Harald Reinhart, Patricia A Bradford
In vitro activity of omadacycline against pathogens isolated from Mainland China during 2017-2018. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 39 (8) (2020)
Andrew R Mack, Melissa D Barnes, Magdalena A Taracila, Andrea M Hujer, Kristine M Hujer, Gabriel Cabot, Michael Feldgarden, Daniel H Haft, William Klimke, Focco van den Akker, Alejandro J Vila, Andrea Smania, Shozeb Haider, Krisztina M Papp-Wallace, Patricia A Bradford, Gian Maria Rossolini, Jean-Denis Docquier, Jean-Marie Frère, Moreno Galleni, Nancy D Hanson, Antonio Oliver, Patrick Plésiat, Laurent Poirel, Patrice Nordmann, Timothy G Palzkill, George A Jacoby, Karen Bush, Robert A Bonomo
A Standard Numbering Scheme for Class C β-Lactamases. Antimicrobial agents and chemotherapy 64 (3) (2020)
Karen Bush, Patricia A Bradford
Epidemiology of β-Lactamase-Producing Pathogens. Clinical microbiology reviews 33 (2) (2020)
Aaron P Mitchell, Ira J Blader, Patricia A Bradford, Sarah E F D'Orazio, W Paul Duprex, Craig D Ellermeier, Ana Fernandez Sesma, Michael J Imperiale, Katherine D McMahon, Marcela F Pasetti, Susannah G Tringe
mSphere of Influence: the View from the Microbiologists of the Future. mSphere 4 (3) (2019)
Alita A Miller, Maria M Traczewski, Michael D Huband, Patricia A Bradford, John P Mueller
Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. Journal of clinical microbiology 57 (9) (2019)
Rodrigo E Mendes, Mariana Castanheira, Leah N Woosley, Gregory G Stone, Patricia A Bradford, Robert K Flamm
Characterization of β-Lactamase Content of Ceftazidime-Resistant Pathogens Recovered during the Pathogen-Directed Phase 3 REPRISE Trial for Ceftazidime-Avibactam: Correlation of Efficacy against β-Lactamase Producers. Antimicrobial agents and chemotherapy 63 (6) (2019)
Aubrey Watson, Jun Taek Oh, Karen Sauve, Patricia A Bradford, Cara Cassino, Raymond Schuch
Antimicrobial Activity of Exebacase (Lysin CF-301) against the Most Common Causes of Infective Endocarditis. Antimicrobial agents and chemotherapy 63 (10) (2019)
Krystyna M Kazmierczak, Patricia A Bradford, Gregory G Stone, Boudewijn L M de Jonge, Daniel F Sahm
In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015. Antimicrobial agents and chemotherapy 62 (12) (2018)
Patricia A Bradford, Michael D Huband, Gregory G Stone
A Systematic Approach to the Selection of the Appropriate Avibactam Concentration for Use with Ceftazidime in Broth Microdilution Susceptibility Testing. Antimicrobial agents and chemotherapy 62 (7) (2018)
Gregory G Stone, Paul Newell, Patricia A Bradford
In Vitro Activity of Ceftazidime-Avibactam against Isolates from Patients in a Phase 3 Clinical Trial for Treatment of Complicated Intra-abdominal Infections. Antimicrobial agents and chemotherapy 62 (7) (2018)
Rodrigo E Mendes, Mariana Castanheira, Leah N Woosley, Gregory G Stone, Patricia A Bradford, Robert K Flamm
Molecular β-Lactamase Characterization of Aerobic Gram-Negative Pathogens Recovered from Patients Enrolled in the Ceftazidime-Avibactam Phase 3 Trials for Complicated Intra-abdominal Infections, with Efficacies Analyzed against Susceptible and Resistant Subsets. Antimicrobial agents and chemotherapy 61 (6) (2017)
James A Karlowsky, Krystyna M Kazmierczak, Boudewijn L M de Jonge, Meredith A Hackel, Daniel F Sahm, Patricia A Bradford
In Vitro Activity of Aztreonam-Avibactam against Enterobacteriaceae and Pseudomonas aeruginosa Isolated by Clinical Laboratories in 40 Countries from 2012 to 2015. Antimicrobial agents and chemotherapy 61 (9) (2017)

Patricia A Bradford.css-eqlu8i{font-size:small;padding-left:4px;} (Patricia Bradford, Fupin Hu)

Publication Activity (10 Years)

Top Topics

Top Venues

Patricia A Bradford (Patricia Bradford, Fupin Hu)